Numbers

The Numbers

Figures converted from INR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Sunteck is a sub-$120 million-revenue developer trying to scale out of project-cycle chop. FY26 revenue jumped 32% and EPS doubled as Mumbai launches monetised, but the cash statement told a different story — operating cash flow swung to negative $46 million as the company poured capital into inventory for its 50 mn sq ft western-suburb pipeline. The market has noticed: the stock is down 13% over the trailing year despite record P&L numbers. The single metric most likely to rerate the share is sustained positive free cash flow alongside continued pre-sales growth — until that pairing arrives, the discount to mid-cap peers is hard to close.

Snapshot

Market cap of ~$551 million puts SUNTECK at roughly 1/30th of DLF and 1/17th of Lodha. Among listed Mumbai-MMR developers it is the smallest at scale, and that smallness compounds the cash-flow lumpiness.

Is it healthy and durable?

The balance sheet is the strong story. Net debt-to-equity is the lowest among MMR peers; liquidity covers committed land payments. Where the company struggles is converting accounting profit to cash and keeping returns above the cost of capital through a full project cycle.

Revenue & earnings power — 12-year view

Two stories visible at once. Revenue troughed in FY23 at $44M — the lowest level since FY16 — as project deliveries paused. The FY24-FY26 ramp is real and the FY26 operating margin of 27% is the highest since FY19, suggesting the new launches carry better-priced inventory. But the 2018-19 peak revenue of ~$135M was earned at 44% margins, and the company has yet to recapture that combination of scale and pricing power.

Quarterly direction

The company has now strung eight consecutive quarters of profitability (1Q25-4Q26), the longest streak in the dataset. 4Q24 was a milestone — the first $50M+ quarter — but the run-rate has actually settled at a more modest $20-38M level, which underlines that revenue recognition is project-completion driven and quarterly comps will stay choppy.

Cash generation — are the earnings real?

This is where the equity story lives or dies for a residential developer in inventory-build mode.

Across the last decade, Sunteck has converted only roughly 30% of reported earnings into operating cash. That is materially lower than the 70-100% range a stable real estate operator should manage. Two things drove FY26's cash drain: inventory days expanded as projects entered active construction, and other liabilities (customer advances) couldn't keep pace with land/WIP outflows.

Capital allocation

The bar pattern reveals discipline followed by a re-leveraging year: FY23-FY25 saw three consecutive years of net debt repayment (negative CFF), but FY26 swung the other way with $57M net financing inflow to fund the inventory build and a $19M investment outflow into fixed assets and projects. Dividends remain token (FY26 payout 11% of NI, ~$2.4M); there are no buybacks. Capital return is not the story here — pipeline build is.

Balance sheet — leverage room

Leverage stayed inside a tight 0.12-0.34x band for a full decade, with FY25 at the lowest point in years (0.12x) before the FY26 step-up to 0.21x to fund pipeline. Even the new level is comfortably below stated peer norms and well inside the AA credit rating envelope from India Ratings (Fitch). Note: management cites "net debt to equity of 0.06-0.07x" using a stricter definition (including current investments and cash) — the directional message is the same.

Valuation — vs its own history

For a residential developer with EPS that swings between $0.001 and $0.26 in a decade, P/B is the cleaner valuation lens than P/E.

The stock currently trades at 1.42x book against a 5-year median of 1.74x — roughly 16% below its own recent average. That is not "screaming cheap": Sunteck has touched 1.0x P/B in FY23 and FY26 trough sessions, and the floor visible in the chart sits around 1.0x. The P/B floor is the asymmetry — equity is well-capitalised and largely real-asset backed, so further multiple compression is bounded.

Stock price decade

The stock printed a multi-year high of $6.61 in early FY22 and has not closed FY higher since. Eight of the last 10 fiscal-year closes sit between $2.78 and $6.61 — it is a range-bound name that has not delivered durable compounding through a cycle.

Peer comparison — MMR/Bengaluru developers

Sunteck trades at the lowest P/B in the peer set (1.42x vs peer median ~3.6x) and the lowest absolute revenue scale. P/E (25.3x) is in line with Lodha (25.7x) but the ROE gap is enormous — 5.9% versus Lodha's 15.8% and Oberoi's 14.7%. The discount is not an opportunity until ROE moves toward the peer median; Sunteck is priced as a smaller, less profitable mid-cap, which is what the financials show.

Fair value & scenario range

A realistic range using P/B reversion plus a peer-discount cross-check:

Analyst consensus target price sits at $5.72 (13 analysts, range $4.53-$9.64) — closer to the bull case than the base. That gap is the alpha if Sunteck delivers, and the risk if it does not.

What the numbers say

The numbers confirm the bull-side framing of FY26: revenue inflected (+32% YoY), margins are at a 7-year high, leverage is well inside the AA-rated envelope, and promoter holding is steady at 63%. The numbers contradict the popular "growth re-acceleration" story in one important way — operating cash flow has not followed earnings; FY26's negative $46M CFO and a 30% 10-year cash conversion ratio suggest reported net income is running ahead of true economic earnings while the company invests in inventory. The single thing to watch over the next four quarters is whether 1H FY27 CFO turns positive on the back of pre-sales conversion — if it does, the P/B discount to peers should compress quickly; if it does not, the stock stays in the $2.90-$4.90 trading range it has occupied since FY22.